Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
AstraZeneca
Daiichi Sankyo
Healthtrust
Queensland Health
Farmers Insurance
US Army
US Department of Justice
Julphar
UBS

Generated: October 22, 2017

DrugPatentWatch Database Preview

AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Aminosyn 4.25% W/ Dextrose 25% In Plastic Container, and when can generic versions of Aminosyn 4.25% W/ Dextrose 25% In Plastic Container launch?

Aminosyn 4.25% W/ Dextrose 25% In Plastic Container is a drug marketed by Abbott and is included in one NDA.

The generic ingredient in AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER is amino acids; dextrose. There are three hundred and forty-one drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; dextrose profile page.

Summary for Tradename: AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER

US Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list607
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott
AMINOSYN 4.25% W/ DEXTROSE 25% IN PLASTIC CONTAINER
amino acids; dextrose
INJECTABLE;INJECTION019119-001Oct 11, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
Boehringer Ingelheim
Dow
Cantor Fitzgerald
Fish and Richardson
Accenture
AstraZeneca
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot